Obesity Clinical Trials

Find Obesity Clinical Trials Near You

The Impact of Cardiometabolic Factors on Coronary Artery and Cardiovascular Diseases: a Prospective Cohort Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Systematic metabolic diseases are closely related to prevalence and progression of atherosclerosis. This prospective cohort consecutively enrolls patients with coronary artery disease compliacted with metabolic abnormalities such as diabtetes, prediabetes, obesity, chronic kidney disease and hyperuricemia.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Age 18-80 years

• Established coronary artery disease or metabolic disorders, including:

‣ Type 2 diabetes diagnosed by one of the following criteria:

‣ HbA1c \>/= 6.5% Fasting plasma glucose \>/= 7.0 mmol/l (confirmed) 2h plasma glucose value during OGTT \>/= 11.1 mmol/l Already receiving glucose-lowering agents

⁃ Prediabetes

⁃ Obesity

⁃ Chronic kidney disease

⁃ Hyperuricemia

⁃ Dyslipidemia

Locations
Other Locations
China
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
RECRUITING
Shanghai
Contact Information
Primary
Xiaoqun Wang, M.D., Ph.D.
xiaoqun_wang@hotmail.com
+86 21 13651839760
Backup
Shuo Feng, M.D.
fengshuorv@hotmail.com
+86 21 15921388296
Time Frame
Start Date: 2017-01-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 3000
Sponsors
Leads: Ruijin Hospital

This content was sourced from clinicaltrials.gov